Healthcare -
Biotechnology - NASDAQ - US
$ 4.8325
124 %
$ 15 M
Market Cap
-0.15
P/E
BTAI - GROSS PROFIT
Gross Profit BTAI - BioXcel Therapeutics, Inc.
120 K
LAST VALUE
55.05%
2 YEAR CAGR
55.39%
5 YEAR CAGR
0.00%
10 YEAR CAGR